The FDA will be holding a public meeting to gather input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. The meeting will be held on 2/2/21 from 10am-2pm and 2/3/21 from 10am-1pm. For more information, click here.

The FDA will be holding a public meeting to gather input on the scientific and ethical issues that surround the inclusion of pregnant women in clinical trials for drug development. The meeting will be held on 2/2/21 from 10am-2pm and 2/3/21 from 10am-1pm. For more information, click here.